ACST News and Press, Acasti Pharma Inc. From 08/31/20

Nano cap Acasti Pharma (NASDAQ: ACST ) announces unsuccessful results from a second Phase 3 clinical trial, TRILOGY 2 , evaluating CaPre (omega-3 phospholipid) for the treatment of patients with very high levels of triglycerides in the blood (hypertriglyceridemia). More news on: Acast...

LAVAL, Québec, Aug. 31, 2020 (GLOBE NEWSWIRE) -- Acasti Pharma Inc.  (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate...

Are Analysts Right About These Penny Stocks? Penny stocks have become a go-to for many traders looking for high-risk, high-reward situations in the stock market. No matter what day it is or what broader markets are doing, you’ll likely find at least one of the stocks under $5 making a...

Looking For Penny Stocks To Trade? I assume penny stocks are something you’re interested in right now. That’s likely the case or you wouldn’t be here, right? Aside from that, even if you’re curious and want to learn how to trade penny stocks , you’ve go...

LAVAL, Québec, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre ...

Cheap Stocks To Watch During The First Week Of August What’s the definition of penny stocks ? If you go by the standard Securities And Exchange Commission overview, these are simply stocks under $5. While some might immediately assume that the exchange plays a factor, for the most pa...

Momentum Traders Are Seeing Huge Wins With Penny Stocks In July When you talk about trading penny stocks , the low price nature opens the door for momentum to push stocks to higher percentages than blue-chips . These moves can come within days or even hours. A clear measure of growing or con...

LAVAL, Québec, July 31, 2020 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre...

Acasti Pharma Inc. (ACST) Q4 2020 Earnings Conference Call June 29, 2020 10:30 AM ET Company Participants Alexandra Botie - Crescendo Communications, LLC Jan D’Alvise - President and CEO Pierre Lemieux - COO, Chief Scientific Officer and Co-Founder Brian Groch - Chief Co...

Identifies “Triglyceride Normalization” phenomenon prior to patient randomization and treatment  as likely contributor to unusually high placebo effect in TRILOGY 1 Acasti management to host conference call at 1 PM ET today LAVAL, Quebec, June 29, 2020 (GLOBE ...